A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Clinical trial NCT06131398 · COMPLETED
Trial details
- NCT number
- NCT06131398
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-07
- Primary completion
- 2026-07-22
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.